FREE Case Review (866) 588-0600

Invokana Ketosis Lawsuit Filed in New Jersey

An Indiana woman who claims that side effects of Invokana caused her to develop severe dehydration and profound ketosis has filed a products liability lawsuit in New Jersey.

An Indiana woman who claims that side effects of the type 2 diabetes drug Invokana (generic: canagliflozin) caused her to develop severe dehydration and profound ketosis has filed a products liability lawsuit in the U.S. District Court for the District of New Jersey.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the problem?

April 6, 2017 – Plaintiff Teresa Ross was prescribed Invokana in 2013 for the treatment of type 2 diabetes. Ross developed starvation ketosis and dehydration in May 2015 as a result of her use of Invokana, according to the lawsuit (PDF).

Starvation ketosis is a metabolic state in which the body breaks down fat and produces acids known as ketones, then uses these as a primary energy source. Ketones are capable of supplying energy to the body, but an abnormally high level can cause a number of problems, including organ damage, coma, and even death. If left untreated, ketosis can ultimately develop into diabetic ketoacidosis (DKA), where high blood acid levels lead to organ damage and typically result in hospitalization.

Plaintiff alleges that she was not adequately warned of Invokana’s potential health risks before she started taking the drug.

“Plaintiff’s injuries were preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions, and willful misrepresentations concerning the nature and safety of Invokana,” the lawsuit states.

Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps control blood sugar in patients with type 2 diabetes. The drug was developed by Mitsubishi Tanabe Pharma, and is marketed under license by Janssen Pharmaceuticals (a Johnson & Johnson company). Invokana was approved by the FDA in March 2013.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) in December ordered that all federal lawsuits alleging diabetic ketoacidosis and kidney failure injuries from Invokana and Invokamet (canagliflozin and metformin) would be transferred to the District of New Jersey for pretrial handling. At the time of the filing, the MDL included about 55 lawsuits alleging that Invokana and Invokamet may cause a number of serious injuries, and that Janssen failed to adequately warn the public and medical community about these risks.

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new ketoacidosis and kidney failure cases in all 50 states.

Free Case Evaluation: Again, if you were injured by the side effects of Invokana, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition